145 related articles for article (PubMed ID: 31356956)
1. Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties.
Rodenak-Kladniew B; Scioli Montoto S; Sbaraglini ML; Di Ianni M; Ruiz ME; Talevi A; Alvarez VA; Durán N; Castro GR; Islan GA
Int J Pharm; 2019 Oct; 569():118575. PubMed ID: 31356956
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity.
Fazly Bazzaz BS; Khameneh B; Namazi N; Iranshahi M; Davoodi D; Golmohammadzadeh S
Lett Appl Microbiol; 2018 Jun; 66(6):506-513. PubMed ID: 29569372
[TBL] [Abstract][Full Text] [Related]
4. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
5. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
[TBL] [Abstract][Full Text] [Related]
6. Targeting of eugenol-loaded solid lipid nanoparticles to the epidermal layer of human skin.
Garg A; Singh S
Nanomedicine (Lond); 2014; 9(8):1223-38. PubMed ID: 23987096
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles.
Xie S; Zhu L; Dong Z; Wang Y; Wang X; Zhou W
Int J Nanomedicine; 2011; 6():547-55. PubMed ID: 21468357
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
[TBL] [Abstract][Full Text] [Related]
12. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
13. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
[TBL] [Abstract][Full Text] [Related]
14. Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and Chitosan Coating.
Eid HM; Elkomy MH; El Menshawe SF; Salem HF
AAPS PharmSciTech; 2019 May; 20(5):183. PubMed ID: 31054011
[TBL] [Abstract][Full Text] [Related]
15. Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing.
Bueloni B; Sanna D; Garribba E; Castro GR; León IE; Islan GA
Int J Biol Macromol; 2020 Oct; 161():1568-1580. PubMed ID: 32777416
[TBL] [Abstract][Full Text] [Related]
16. Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: Antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies.
Severino P; Chaud MV; Shimojo A; Antonini D; Lancelloti M; Santana MH; Souto EB
Colloids Surf B Biointerfaces; 2015 May; 129():191-7. PubMed ID: 25863712
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
18. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
19. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.
Gaspar DP; Faria V; Gonçalves LM; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2016 Jan; 497(1-2):199-209. PubMed ID: 26656946
[TBL] [Abstract][Full Text] [Related]
20. PEGylated ofloxacin nanoparticles render strong antibacterial activity against many clinically important human pathogens.
Marslin G; Revina AM; Khandelwal VK; Balakumar K; Sheeba CJ; Franklin G
Colloids Surf B Biointerfaces; 2015 Aug; 132():62-70. PubMed ID: 26005932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
